C30H35N3O11S — CID 164715892
3-[2-[[(6aS)-6-hydroxy-2-methoxy-8-[4-(methylsulfamoyl)phenyl]-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,10-tetrahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]ethoxy]propanoic acid (PubChem CID 164715892) has the molecular formula C30H35N3O11S and a molecular weight of 645.69 g/mol. Its IUPAC name is 3-[2-[[(6aS)-6-hydroxy-2-methoxy-8-[4-(methylsulfamoyl)phenyl]-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,10-tetrahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]ethoxy]propanoic acid.
| Compound Name | 3-[2-[[(6aS)-6-hydroxy-2-methoxy-8-[4-(methylsulfamoyl)phenyl]-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,10-tetrahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]ethoxy]propanoic acid |
|---|---|
| PubChem CID | 164715892 |
| Molecular Formula | C30H35N3O11S |
| Molecular Weight | 645.69 g/mol |
| Exact Mass | 645.20 |
| IUPAC Name | 3-[2-[[(6aS)-6-hydroxy-2-methoxy-8-[4-(methylsulfamoyl)phenyl]-12-oxo-5-prop-2-enoxycarbonyl-6,6a,7,10-tetrahydropyrido[2,1-c][1,4]benzodiazepin-3-yl]oxy]ethoxy]propanoic acid |
| SMILES | C=CCOC(=O)N1c2cc(OCCOCCC(=O)O)c(OC)cc2C(=O)N2CC=C(c3ccc(S(=O)(=O)NC)cc3)C[C@H]2C1O |
| InChI | InChI=1S/C30H35N3O11S/c1-4-12-44-30(38)33-23-18-26(43-15-14-42-13-10-27(34)35)25(41-3)17-22(23)28(36)32-11-9-20(16-24(32)29(33)37)19-5-7-21(8-6-19)45(39,40)31-2/h4-9,17-18,24,29,31,37H,1,10-16H2,2-3H3,(H,34,35)/t24-,29?/m0/s1 |
| InChIKey | AENNXFGZXBZOCO-CTLOQAHHSA-N |
| XLogP | 2.23 |
| TPSA | 181.24 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 45 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 645.69 |
| LogP ≤ 5 | 2.23 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|